ARTICLE | Company News
Catalyst Biosciences, Torrey Pines Institute for Molecular Studies deal
August 1, 2005 7:00 AM UTC
Catalyst received an exclusive worldwide license to the institute's IP covering protease engineering, selection and optimization. Catalyst is developing engineered proteases to treat inflammation and ...